These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 24204912)

  • 21. Combination antiretroviral therapy with raltegravir leads to rapid immunologic reconstitution in treatment-naive patients with chronic HIV infection.
    Pallikkuth S; Fischl MA; Pahwa S
    J Infect Dis; 2013 Nov; 208(10):1613-23. PubMed ID: 23922374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term immunological response in HIV-1-infected subjects receiving potent antiretroviral therapy.
    Kaufmann GR; Bloch M; Zaunders JJ; Smith D; Cooper DA
    AIDS; 2000 May; 14(8):959-69. PubMed ID: 10853977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poor CD4/CD8 ratio recovery in HBcAb-positive HIV patients with worse immune status is associated with significantly higher CD8 cell numbers.
    Malagnino V; Cerva C; Teti E; Campogiani L; Compagno M; Foroghi Biland L; Saderi L; Armenia D; Salpini R; Svicher V; Sotgiu G; Iannetta M; Andreoni M; Sarmati L
    Sci Rep; 2021 Feb; 11(1):3965. PubMed ID: 33597631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of extended-release niacin on immune activation and neurocognition in HIV-infected patients treated with antiretroviral therapy - CTN PT006: study protocol for a randomized controlled trial.
    Lebouché B; Jenabian MA; Singer J; Graziani GM; Engler K; Trottier B; Thomas R; Brouillette MJ; Routy JP
    Trials; 2014 Oct; 15():390. PubMed ID: 25293882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low CD4/CD8 Ratio Is Associated with Non AIDS-Defining Cancers in Patients on Antiretroviral Therapy: ANRS CO8 (Aproco/Copilote) Prospective Cohort Study.
    Hema MN; Ferry T; Dupon M; Cuzin L; Verdon R; Thiébaut R; Protopopescu C; Leport C; Raffi F; Le Moing V;
    PLoS One; 2016; 11(8):e0161594. PubMed ID: 27548257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002.
    Bonnet F; Thiébaut R; Chêne G; Neau D; Pellegrin JL; Mercié P; Beylot J; Dabis F; Salamon R; Morlat P;
    HIV Med; 2005 May; 6(3):198-205. PubMed ID: 15876287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical, immunological, and virological outcomes of pediatric antiretroviral therapy in central China.
    Zheng J; Zhao D
    BMC Res Notes; 2014 Jul; 7():419. PubMed ID: 24994004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent trends in early stage response to combination antiretroviral therapy in Australia.
    McManus H; Hoy JF; Woolley I; Boyd MA; Kelly MD; Mulhall B; Roth NJ; Petoumenos K; Law MG;
    Antivir Ther; 2015; 20(2):131-9. PubMed ID: 24704818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection.
    Plana M; García F; Gallart T; Tortajada C; Soriano A; Palou E; Maleno MJ; Barceló JJ; Vidal C; Cruceta A; Miró JM; Gatell JM
    AIDS; 2000 Sep; 14(13):1921-33. PubMed ID: 10997396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus-Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC).
    Trickey A; May MT; Schommers P; Tate J; Ingle SM; Guest JL; Gill MJ; Zangerle R; Saag M; Reiss P; Monforte AD; Johnson M; Lima VD; Sterling TR; Cavassini M; Wittkop L; Costagliola D; Sterne JAC;
    Clin Infect Dis; 2017 Sep; 65(6):959-966. PubMed ID: 28903507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD4/CD8 Ratio Recovery of Children and Adolescents Living With HIV With Virological Suppression: A Prospective Cohort Study.
    Han WM; Apornpong T; Handoko R; Jantarabenjakul W; Gatechompol S; Ubolyam S; Kerr SJ; Avihingsanon A; Ruxrungtham K; Phanuphak P; Puthanakit T
    J Pediatric Infect Dis Soc; 2021 Mar; 10(2):88-96. PubMed ID: 32188991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD4+/CD8+ ratio restoration in long-term treated HIV-1-infected individuals.
    Caby F;
    AIDS; 2017 Jul; 31(12):1685-1695. PubMed ID: 28700392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T-cell changes after a short-term exposure to maraviroc in HIV-infected patients are related to antiviral activity.
    Pulido I; Machmach K; Romero-Sánchez MC; Genebat M; Mendez-Lagares G; Ruiz-Mateos E; Leal M
    J Infect; 2012 Apr; 64(4):417-23. PubMed ID: 22227467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD4/CD8 ratio normalization rates and low ratio as prognostic marker for non-AIDS defining events among long-term virologically suppressed people living with HIV.
    Han WM; Apornpong T; Kerr SJ; Hiransuthikul A; Gatechompol S; Do T; Ruxrungtham K; Avihingsanon A
    AIDS Res Ther; 2018 Sep; 15(1):13. PubMed ID: 30261902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiretroviral Regimens and CD4/CD8 Ratio Normalization in HIV-Infected Patients during the Initial Year of Treatment: A Cohort Study.
    De Salvador-Guillouët F; Sakarovitch C; Durant J; Risso K; Demonchy E; Roger PM; Fontas E
    PLoS One; 2015; 10(10):e0140519. PubMed ID: 26485149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of cytokines in the pathogenesis and treatment of HIV infection.
    Catalfamo M; Le Saout C; Lane HC
    Cytokine Growth Factor Rev; 2012; 23(4-5):207-14. PubMed ID: 22738931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term and long-term clinical and immunological consequences of stopping antiretroviral therapy in HIV-infected patients with preserved immune function.
    Imaz A; Olmo M; Peñaranda M; Gutiérrez F; Romeu J; Larrousse M; Domingo P; Oteo JA; Curto J; Vilallonga C; Masiá M; López-Aldeguer J; Iribarren JA; Podzamczer D;
    Antivir Ther; 2013; 18(1):125-30. PubMed ID: 22805174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cocaine reduces thymic endocrine function: another mechanism for accelerated HIV disease progression.
    Rafie C; Campa A; Smith S; Huffman F; Newman F; Baum MK
    AIDS Res Hum Retroviruses; 2011 Aug; 27(8):815-22. PubMed ID: 21142650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD4/CD8 ratio improvement in HIV-1-infected patients receiving dual antiretroviral treatment.
    Monsalvo M; Vallejo A; Fontecha M; Vivancos MJ; Vizcarra P; Casado JL
    Int J STD AIDS; 2019 Jun; 30(7):656-662. PubMed ID: 30961467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD4
    Vivancos-Gallego MJ; Okhai H; Perez-Elías MJ; Gomez-Ayerbe C; Moreno-Zamora A; Casado JL; Quereda C; Sanz JM; Sanchez-Conde M; Serrano-Villar S; Del Campo S; Dronda F; Galan JC; Sabin CA; Moreno S
    Antivir Ther; 2020; 25(2):91-100. PubMed ID: 32338638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.